Back to dashboard
Episode 166
DIP Episode 166 - USMLE Step 2CK Rapid Review Series 20 (Psych)
PsychiatryMedium4 - HighHas Q&A
Step 2Step 3PsychiatryUSMLEStep 2Step 3
Topic
Bipolar Disorder diagnosis and management; Lithium toxicity (Nephrogenic DIADH)...
Key Takeaway
Lithium is the drug of choice for treating Bipolar Disorder due to its anti-suicidal properties, but clinicians must monitor for nephrogenic diabetes insipidus and avoid thiazide diuretics when managing volume depletion or DIADH associated with lithium use.
Runtime: 23.7 min
Published: 2019-10-09
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW SERIES
Episode Notes
Source / episode info
- Episode: 166
- Title: Divine Intervention Episode 166 – USMLE Step 2 CK Rapid Review Series 20 (Psych).
- Published: 2019-10-09
- Source: Episode page
One-liner
This episode reviews high-yield psychopharmacology concepts, focusing on the diagnosis of Bipolar Disorder (manic/depressive episodes), the unique toxicities and management of Lithium (especially nephrogenic DIADH), and common side effects associated with SSR Is and SNR Is.
High-yield summary
- Bipolar Diagnosis: Requires at least one manic episode (or hypomanic, depending on severity) AND a depressive episode for full diagnosis; however, the presence of a clear manic episode alone can meet criteria if symptoms persist >1 week (unless social dysfunction/hospitalization is required).
- Lithium Toxicity & DIADH: Lithium causes nephrogenic diabetes insipidus by interfering with the inositol channel in the collecting duct principal cells. Treatment requires K+-sparing diuretics (Amiloride or Triamterene) and avoiding thiazides (like HCTZ) because volume depletion increases RAAS activity, worsening lithium reabsorption.
- Acute Mania Management: When a patient is acutely manic, the initial treatment involves an anti-psychotic agent, with Lithium added concurrently for long-term maintenance therapy.
- SSRI/SNRI Side Effects: SSR Is are associated with sexual dysfunction (low libido) and can be used to treat Premenstrual Dysphoric Disorder (PMDD) or premature ejaculation by exploiting this side effect. SNR Is (e.g., Venlafaxine) carry a risk of hypertension.
- MDD Criteria: Diagnosis requires 5 out of 9 CIGI-CAP symptoms for at least two weeks, with the absence of a major depressive episode preceding the onset of mania/hypomania to rule out Bipolar Disorder.
Learning objectives
- Differentiate the diagnostic criteria for Major Depressive Disorder (MDD) versus Bipolar Disorder.
- Identify the drug class and mechanism responsible for lithium's anti-suicidal properties.
- Recognize the signs, symptoms, and underlying pathophysiology of nephrogenic diabetes insipidus associated with lithium use.
- Select appropriate agents to treat lithium-induced DIADH while avoiding those that exacerbate RAAS activity (e.g., thiazides).
- Correlate common psychotropic drug side effects (e.g., SSRI sexual dysfunction, SNRI hypertension) with clinical management strategies.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Bipolar Disorder | Manic/Depressive Episodes | Lithium; Anti-psychotics | Remember that the anti-suicidal properties of lithium are a high-yield fact. |
| Nephrogenic DIADH | Polyuria, Polydipsia, Hypernatremia | Lithium; Inositol channel blockade (E NaC) | Always think K+-sparing diuretics (Amiloride/Triamterene) when treating this complication. |
| SSR Is | Sexual Dysfunction (Low Libido) | Serotonin reuptake inhibition | This side effect can be exploited therapeutically (e.g., for PMDD or premature ejaculation). |
| SNRI (Venlafaxine) | Hypertension | Increased sympathetic tone/NE effects | If a psych drug causes hypertension, suspect an SNRI class agent. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Bipolar Dx | Manic episode + Depressive episode (or just Mania) | Diagnosis requires symptoms for >1 week; exception applies if social dysfunction/hospitalization is needed. | Distinguishing Bipolar Disorder from MDD based on symptom history and duration. |
| Lithium Toxicity | Nephrogenic DIADH | Lithium interferes with the inositol channel in collecting duct principal cells. | Critical management point: Avoid thiazides (HCTZ) due to RAAS activation risk. |
| MDD Criteria | 5 out of 9 CIGI-CAP symptoms for 2 weeks | Must rule out mania/hypomania; symptom onset must be recent and not related to life stress. | Trap question: Do not confuse the required number of symptoms or duration. |
| Acute Mania Tx | Anti-psychotic + Lithium (for maintenance) | Initial stabilization requires an antipsychotic, followed by lithium for long-term mood stability. | Knowing that acute management differs from chronic maintenance therapy is key. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with grandiosity, decreased need for sleep, and flight of ideas over 10 days. | Manic Episode (Bipolar Dx) | These are classic signs of mania; the duration (>7 days) confirms the severity required for diagnosis. |
| A woman taking lithium develops polyuria and polydipsia refractory to vasopressin, accompanied by hypernatremia. | Nephrogenic Diabetes Insipidus (DIADH) | Lithium interferes with ADH action in the collecting duct principal cells, leading to impaired water reabsorption. |
| A patient on lithium presents with volume depletion and worsening DIADH. The physician should add which drug? | Amiloride or Triamterene (K+-sparing diuretics) | These agents block the epithelial sodium channel (E NaC), counteracting the RAAS-mediated increase in lithium reabsorption, unlike thiazides. |
| A patient with Bipolar Disorder is acutely manic and requires immediate stabilization. The initial treatment should be: | Anti-psychotic agent + Lithium | An anti-psychotic addresses acute symptoms; Lithium is added for long-term mood stabilization/maintenance therapy. |
| A young man presents to the clinic complaining of low libido and difficulty achieving orgasm after starting an SSRI for GAD. | Sexual Dysfunction (SSRI side effect) | This is a common, expected adverse effect of SSR Is due to serotonin receptor activity in sexual pathways. |
| A patient with suspected Bipolar Disorder has been stable on lithium but develops symptoms suggestive of hypothyroidism. | Lithium-induced Hypothyroidism | Lithium frequently causes thyroid dysfunction and requires baseline TSH monitoring; treatment may involve levothyroxine. |
Differential diagnosis / distinguishing features
Nephrogenic DIADH vs Primary Polydipsia
| Key Features | Distinguishing Findings | Next Step |
| Nephrogenic DIADH: Kidney failure to respond to ADH (vasopressin). | Primary Polydipsia: Excessive fluid intake leading to dilution/overhydration. | Measure urine osmolality and serum sodium; if high Uosm despite low plasma osmolality, consider nephrogenic cause. |
SSRI vs SNRI side effects
| Key Features | Distinguishing Findings | Next Step |
| SSRI: Primarily inhibits Serotonin reuptake (e.g., Fluoxetine). | SNRI: Inhibits both Serotonin and Norepinephrine reuptake (e.g., Venlafaxine). | If hypertension is suspected, consider switching from an SSRI to a tricyclic or vice versa; suspect SNR Is first. |
Management pearls
- Lithium Monitoring: Always obtain baseline TSH before initiating lithium therapy due to the risk of hypothyroidism.
- Acute Mania Stabilization: For acute mania, initiate treatment with an anti-psychotic agent and start lithium concurrently for long-term mood stabilization; do not wait for symptoms to resolve naturally.
- Treating Lithium-Induced DIADH: Use K+-sparing diuretics (Amiloride or Triamterene) because they block the E NaC channel, which is independent of RAAS activity and does not worsen lithium reabsorption.
- PMDD Treatment: SSR Is are first-line agents for PMDD; these drugs can also be used to treat generalized anxiety disorder (GAD).
Don't miss
🚨
Lithium's anti-suicidal properties: It is one of only two psychotropics (the other being Clozapine) proven to reduce suicide risk.
🚨
HCTZ/Thiazides: Never use thiazide diuretics in a patient with suspected lithium toxicity or nephrogenic DIADH, as they increase RAAS activity and worsen lithium retention.
🚨
CIGI-CAP Acronym: Remember the 5 out of 9 symptoms (Sleep loss, Loss of interest, Guilt, Energy decrease, Poor concentration, Appetite issues, Psychomotor retardation, Suicidal ideation).
Integration & clinical reasoning
- Psychiatry & Endocrine System: Lithium toxicity provides a classic example of drug interaction with renal physiology. The mechanism involves the interference with the inositol channel (E NaC) in the collecting duct principal cells, linking psychopharmacology to nephrology.
- SSRI/SNRI and Sexual Health: The common side effect of sexual dysfunction can be therapeutically leveraged for conditions like premature ejaculation or PMDD, demonstrating a functional understanding of drug mechanisms beyond just adverse effects.
Concept connections / cross-references
- For detailed review on the endocrine system and renal physiology (e.g., RAAS, ADH), see Episode 137.
- For general psychopharmacology principles, refer to [Episode 165].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Bipolar Disorder | Lithium | Mood stabilizer; decreases suicide risk | Cornerstone of chronic psychiatric management; requires careful monitoring for toxicity. |
| Nephrogenic DIADH | Amiloride/Triamterene | Blocks E NaC channel in collecting duct principal cells | Used to treat lithium-induced polyuria without exacerbating RAAS activity. |
| SSR Is | Sexual Dysfunction (Low Libido) | Serotonin reuptake inhibition | Can be used therapeutically for PMDD or premature ejaculation by exploiting the side effect. |
| SNRI (Venlafaxine) | Hypertension | Increased sympathetic tone/NE effects | Requires monitoring of blood pressure; often a differential diagnosis when hypertension is suspected in psych patients. |
Key terms glossary
| Term | Definition | Context | Example |
| Manic Episode | Distinct period of abnormally and persistently elevated, expansive, or irritable mood AND increased activity/energy lasting 1 week. | Bipolar Disorder diagnosis. | Grandiosity, decreased need for sleep, flight of ideas. |
| Nephrogenic DIADH | Kidney inability to respond to ADH (vasopressin), leading to excessive free water loss. | Lithium toxicity; collecting duct principal cell dysfunction. | Polyuria and hypernatremia in a patient taking lithium. |
| CIGI-CAP | Acronym for 9 symptoms of MDD: Sleep, Loss of interest, Guilt, Energy decrease, Poor concentration, Appetite issues, Psychomotor retardation, Suicidal ideation. | Major Depressive Disorder diagnosis. | Requires 5 symptoms present for 2 weeks. |
| K+-Sparing Diuretics | Thiazides that block the E NaC channel (e.g., Amiloride). | Treatment of DIADH associated with lithium use. | Used instead of HCTZ when managing lithium-induced polyuria. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Bipolar Disorder | Master the diagnostic criteria and acute vs. chronic management strategies. | High | Review flowcharts for mania/depression; memorize drug classes (mood stabilizers). |
| Lithium Toxicity | Focus on mechanism of DIADH and contraindicated drugs. | Critical | Use mnemonics: "L-DIADH -> Avoid Thiazides, Use Amiloride." |
| Psychopharmacology Side Effects | Create association tables linking drug class/drug to common side effect (e.g., SSRI -> Sexual Dysfunction). | Medium-High | Practice vignettes that present a symptom and ask for the most likely causative drug class. |
Question pattern recognition
- Diagnosis Pattern: Recognizing which constellation of symptoms defines a specific mood disorder (Bipolar vs MDD).
- Toxicology/Mechanism Pattern: Understanding how a drug interferes with a physiological process (Lithium -> E NaC channel blockade in collecting duct).
- Management Algorithm Pattern: Knowing the sequence of care for acute crises (e.g., Acute Mania: Antipsychotic first, then Lithium added).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing Bipolar and MDD Dx. Assuming that the presence of depressive symptoms automatically means Bipolar Disorder. Correction: Always screen for a history of mania/hypomania first.
🚫
Mistake 2: Using Thiazides in DIADH. Thinking HCTZ is appropriate for polyuria. Correction: Thiazides increase RAAS activity, worsening lithium retention and toxicity; use K+-sparing diuretics instead.
🚫
Mistake 3: Misunderstanding the "One Week Rule." Assuming that if a person has manic symptoms for only 6 days, it cannot be Bipolar Disorder. Correction: The one-week rule is waived if there is significant social dysfunction or hospitalization required.
Common traps
⚠️
Trap 1 (Lithium): Being asked to treat DIADH with an agent that increases RAAS activity (e.g., HCTZ). Remember: K+-sparing diuretics are the answer.
⚠️
Trap 2 (Bipolar Dx): Presenting a patient who has only had depressive symptoms but also mentions past periods of "feeling great" or "high energy." Always ask about elevated mood states to rule out Bipolar Disorder.
⚠️
Trap 3 (SSRI/SNRI): Assuming that sexual dysfunction is only an adverse effect. Remember it can be therapeutically exploited for PMDD or premature ejaculation.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Renal & Ureteral Viscerosomatic Reflexes (T10–L2): Kidneys and upper ureters receive sympathetic innervation from T10–T11 (aorticorenal ganglion), with Vagus nerve parasympathetics. Lower ureters and bladder receive sympathetics from T12–L2, with Pelvic Splanchnic parasympathetics (S2–S4). Acute nephrolithiasis causes intense paraspinal spasm from T10 to L2.
- Chapman Reflex Points: Kidney anterior point is 1 inch superior and 1 inch lateral to the umbilicus (posterior: T12–L1 intertransverse space). Bladder anterior point is periumbilical and over the pubic symphysis.
- Psoas Spasm in Ureteral Colic: The ureter courses along the anterior surface of the psoas major muscle. A passing calculus irritates the psoas, inducing secondary psoas spasm, pelvic sidebending, and compensatory non-neutral lumbar somatic dysfunction (L1–L2 flexed, sidebent, and rotated).